Nasdaq-100 & Eli Lilly and Company
3 shared events · Importance 3 · Last updated Jun 12, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Nasdaq-100: The Nasdaq-100 Index led the gains among major indexes, significantly boosted by chipmakers and AI-related companies.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
May 20, 2026 · 72 articles
Domestic
Nasdaq-100: The Nasdaq-100 exchange also experienced more advancing issues than decliners, contributing to the overall positive market performance.
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
Apr 01, 2026 · 14 articles
Business
Nasdaq-100: SpaceX debuted on the Nasdaq-100 exchange, which revised its rules to allow for faster inclusion of major IPOs like SpaceX into its indexes, facilitating greater investor access.
Eli Lilly and Company: Eli Lilly and Company is mentioned as one of the companies that SpaceX's valuation will surpass, emphasizing the magnitude of SpaceX's market entry.
Mar 09, 2018 · 538 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Nasdaq-100 and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard